| __timestamp | Perrigo Company plc | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 675200000 | 7751000 |
| Thursday, January 1, 2015 | 771800000 | 10251000 |
| Friday, January 1, 2016 | 1205500000 | 9575000 |
| Sunday, January 1, 2017 | 1146500000 | 10912000 |
| Monday, January 1, 2018 | 1125800000 | 11049000 |
| Tuesday, January 1, 2019 | 1166100000 | 11646000 |
| Wednesday, January 1, 2020 | 1175500000 | 13265000 |
| Friday, January 1, 2021 | 1111400000 | 25805000 |
| Saturday, January 1, 2022 | 1210100000 | 35182000 |
| Sunday, January 1, 2023 | 1274600000 | 94999000 |
Igniting the spark of knowledge
In the ever-evolving landscape of corporate finance, understanding cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Perrigo Company plc and Viridian Therapeutics, Inc. over the past decade. Perrigo, a global leader in consumer self-care products, has seen its SG&A expenses grow by approximately 89% from 2014 to 2023, reflecting strategic investments and market expansion. In contrast, Viridian Therapeutics, a burgeoning player in the biotech sector, experienced a staggering 1,125% increase in SG&A expenses during the same period, indicative of its aggressive growth strategy and scaling operations. This juxtaposition highlights the diverse approaches companies take in managing operational costs, offering valuable insights into their financial health and strategic priorities. As businesses navigate the complexities of the modern economy, these insights serve as a beacon for investors and stakeholders alike.
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Viatris Inc. and Perrigo Company plc: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Corcept Therapeutics Incorporated and Perrigo Company plc: SG&A Spending Patterns Compared
Axsome Therapeutics, Inc. or Perrigo Company plc: Who Manages SG&A Costs Better?
Viking Therapeutics, Inc. and Perrigo Company plc: SG&A Spending Patterns Compared
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.
Perrigo Company plc or Xencor, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.